Status:
COMPLETED
Genicular Nerve Block in Juvenile Idiopathic Arthritis
Lead Sponsor:
Sohag University
Conditions:
Juvenile Idiopathic Arthritis
Persistent Knee Arthritis
Eligibility:
All Genders
Up to 16 years
Phase:
PHASE4
Brief Summary
N=104 juvenile idiopathic arthritis patients diagnosed after ILAR criteria with unilateral persistent knee arthritis. They will be randomly assigned into two groups; group 1 will receive genicular ner...
Eligibility Criteria
Inclusion
- juvenile idiopathic arthritis with persistent knee arthritis
- age below 16
Exclusion
- severe knee osteoarthritis
- peripheral neuropathy,
- psoriatic arthritis,
- those under anticoagulant therapy, skin infection,
- prior knee injection in the last 3 months3
- those who have an allergy to Bupivacaine
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2021
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04687930
Start Date
December 1 2020
End Date
February 15 2021
Last Update
July 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university
Sohag, Egypt, 82749